Altered expression of lysosomal hydrolase, acid α-glucosidase, gene in coronary artery disease

Jingyi Zhang1, Ling Ma, Junping Zhang

  • 1aCollege of Clinical Medicine, Xinxiang Medical University, Xinxiang, Henan bDivision of Cardiology cShandong Provincial Key Laboratory of Cardiac Disease Diagnosis and Treatment, Affiliated Hospital of Jining Medical University, Jining Medical University, Shandong, China.

Coronary Artery Disease
|November 19, 2015
PubMed

Insights

Gene expression of acid α-glucosidase (GAA) is significantly increased in coronary artery disease (CAD) patients. This suggests a potential role for GAA in the development of atherosclerosis and CAD.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Disease Research

Background:

  • Coronary artery disease (CAD) is a complex condition driven by atherosclerosis.
  • Autophagy, a cellular process involving lysosomes, plays a role in lipid and cholesterol metabolism.
  • Previous studies indicated altered expression of autophagic and lysosomal genes in CAD patients.

Purpose of the Study:

  • To investigate the gene expression of acid α-glucosidase (GAA), a lysosomal hydrolase, in patients with CAD.
  • To compare GAA expression levels between CAD patients and ethnically matched controls.

Main Methods:

  • Examined GAA gene expression in large cohorts of CAD patients (n=248) and controls (n=208).
  • Assessed GAA enzymatic activity, protein levels, and transcript levels.
  • Utilized multivariate logistic regression analysis including GAA transcript level, hypertension, diabetes, and smoking.

Main Results:

  • GAA enzymatic activity and transcription levels were significantly elevated in CAD patients compared to controls (P<0.05 and P<0.01, respectively).
  • GAA transcript levels showed a strong association with CAD (odds ratio 5.93, P=3.89×10(-7)).
  • GAA protein levels showed an insignificant increase in CAD patients, potentially due to assay limitations.

Conclusions:

  • GAA gene expression is significantly increased in CAD patients.
  • These findings suggest that GAA may play a role in the pathogenesis of coronary artery disease.
Abstract

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
957
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76